BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12477313)

  • 1. Difficulties associated with the development and licensing of vaccines for protection against bio-warfare and bio-terrorism.
    Langford MJ; Myers RC
    Dev Biol (Basel); 2002; 110():107-12. PubMed ID: 12477313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive vaccines against bioterrorism: evaluation of efficacy and safety.
    Horne AD; Clifford J; Goldenthal KL; Kleppinger C; Lachenbruch PA
    Vaccine; 2004 Nov; 23(1):84-90. PubMed ID: 15519711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of vaccines for bio-warfare agents.
    Rosenthal SR; Clifford JC
    Dev Biol (Basel); 2002; 110():99-105. PubMed ID: 12477312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potency assays for therapeutic live whole cell cancer vaccines.
    Petricciani J; Egan W; Vicari G; Furesz J; Schild G
    Biologicals; 2007 Apr; 35(2):107-13. PubMed ID: 16882459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines against biologic agents: uses and developments.
    Ales NC; Katial RK
    Respir Care Clin N Am; 2004 Mar; 10(1):123-46. PubMed ID: 15062232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines for the prevention of diseases caused by potential bioweapons.
    Hassani M; Patel MC; Pirofski LA
    Clin Immunol; 2004 Apr; 111(1):1-15. PubMed ID: 15093546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory expectations during product development for tumour vaccines.
    Kawakami K; Puri RK
    Dev Biol (Basel); 2004; 116():53-9; discussion 69-76. PubMed ID: 15603183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Salmonella vaccines for biodefence.
    Atkins HS; Morton M; Griffin KF; Stokes MG; Nataro JP; Titball RW
    Vaccine; 2006 Apr; 24(15):2710-7. PubMed ID: 16434131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory pathways for vaccines for developing countries.
    Milstien J; Belgharbi L
    Bull World Health Organ; 2004 Feb; 82(2):128-33. PubMed ID: 15042235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomics and future biological weapons: the need for preventive action by the biomedical community.
    Fraser CM; Dando MR
    Nat Genet; 2001 Nov; 29(3):253-6. PubMed ID: 11687792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive models and correlates of protection for testing biodefence vaccines.
    Williamson ED; Duchars MG; Kohberger R
    Expert Rev Vaccines; 2010 May; 9(5):527-37. PubMed ID: 20450327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory constraints as seen from the pharmaceutical industry.
    Galligani G; David-Andersen I; Fossum B
    Dev Biol (Basel); 2005; 121():235-41. PubMed ID: 15962486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plants as biofactories for the production of subunit vaccines against bio-security-related bacteria and viruses.
    Rigano MM; Manna C; Giulini A; Vitale A; Cardi T
    Vaccine; 2009 May; 27(25-26):3463-6. PubMed ID: 19460602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chapter 27: Research needs following initial licensure of virus-like particle HPV vaccines.
    Hildesheim A; Markowitz L; Avila MH; Franceschi S
    Vaccine; 2006 Aug; 24 Suppl 3():S3/227-32. PubMed ID: 16950011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA perspective on antivirals against biothreats: communicate early and often.
    Roberts R; Styrt B; McCune S
    Antiviral Res; 2008 Apr; 78(1):60-3. PubMed ID: 18037169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dengue fever: from disease to vaccination].
    Teyssou R
    Med Trop (Mars); 2009 Aug; 69(4):333-4. PubMed ID: 19725380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination strategies for Francisella tularensis.
    Isherwood KE; Titball RW; Davies DH; Felgner PL; Morrow WJ
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1403-14. PubMed ID: 15919131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.